Artivion (AORT) Share-based Compensation Growth (3y) (2013 - 2026)
Artivion (AORT) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 8.37% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -28.31% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 13.19% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.11% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -0.59% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 17.13% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 36.49% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.40% |
| 10 | Artivion | 1.37 Bn | 1.29 Bn | 80.52 Mn | 27.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.51% |
| Mar 31, 2026 | 36.05% |
| Dec 31, 2025 | 36.66% |
| Sep 30, 2025 | 25.70% |
| Jun 30, 2025 | 11.89% |
| Mar 31, 2025 | 66.91% |
| Dec 31, 2024 | 455.52% |
| Sep 30, 2024 | 220.02% |
| Jun 30, 2024 | 203.56% |
| Mar 31, 2024 | 9.67% |
| Dec 31, 2023 | -57.75% |
| Sep 30, 2023 | 8.17% |
| Jun 30, 2023 | 13.67% |
| Mar 31, 2023 | 24.97% |
| Dec 31, 2022 | -19.84% |
| Sep 30, 2022 | 169.39% |
| Jun 30, 2022 | 196.29% |
| Mar 31, 2022 | 135.77% |
| Dec 31, 2021 | -84.98% |
| Sep 30, 2021 | -2.74% |